Abstract

BackgroundBy secreting numerous adipocytokines adipose tissue contributes to the development of cardiovascular diseases (CVD) and diabetes while its role in rheumatoid arthritis (RA) and osteoarthritis (OA) is less known. The...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Distinct Secretory Activity and Clinical Impact of Subcutaneous Abdominal Adipose Tissue in Women with Rheumatoid Arthritis and Osteoarthritis.
Krystyna Księżopolska-Orłowska ... Włodzimierz Maśliński
Inflammation | VOL. 40
Krystyna Księżopolska-Orłowska, et. al.Krystyna Księżopolska-Orłowska ... Włodzimierz Maśliński
28 Oct 2016
Syndecan-4 is correlated with disease activity and serological characteristic of rheumatoid arthritis
Xia Ye ... Zhuoli Zhang
Advances in Rheumatology | VOL. 62
Xia Ye, et. al.Xia Ye ... Zhuoli Zhang
20 Jun 2022
Chondrogenic and osteogenic potential of adipose derived stem cells from RA and OA patients
W Maslinski ... U Skalska
Annals of the Rheumatic Diseases | VOL. 70
W Maslinski, et. al.W Maslinski ... U Skalska
01 Mar 2011
AB0111 THE COMPARISON OF SYNDECAN-4 LEVEL IN SERA, SYNOVIAL FLUID AND SYNOVIUM OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS
X Ye ... J Zhao
-
X Ye, et. al.X Ye ... J Zhao
01 Jun 2020
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers